Munawar Hussain
Research Subjects
Munawar Hussain has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Frank K. Gehring
Biosensor Research Group, Thoracic, Cardiac and Vascular Surgery Department, Tuebingen University, Germany
2 shared publications- Frank K. Gehring
Biosensor Research Group, Institute of Clinical and Experimental Transfusion Medicine and Centre of Clinical Transfusion Medicine (ZKT), Tuebingen University and German Red Cross Blood Transfusion Service BW/H, Germany
2 shared publications Hinnak Northoff
Institute of Clinical and Experimental Transfusion Medicine, Tuebingen University, Germany
2 shared publications- Peter Alexander Lieberzeit
University of Vienna
2 shared publications Christian von Heymann
Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institut of Health, Germany; Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Campus Virchow Klinkum, Augustenburger Platz 1, 13353 Berlin, Germany; Vivantes Klinikum im Friedrichshain, Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, Landsberger Allee 49, 10249 Berlin, Germany
1 shared publicationElisabeth Langer
Labor Berlin-Charite Vivantes, GmbH, Berlin, Germany; Institute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-Universitätsmedizin Berlin, Campus Charité Virchow Klinikum, Berlin, Germany
1 shared publication
Latest Publications
- 1 May 2018
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 102, 194-209
Bioapplications of acoustic crystals, a review
- 1 May 2018
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 102, 194-209
Bioapplications of acoustic crystals, a review
- 1 May 2018
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 104, 15-20
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders
- 1 May 2018
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 104, 15-20
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders
- Open Access
Molecularly Imprinted Polymer Nanoparticles for Formaldehyde Sensing with QCM
Herein, we report on molecularly imprinted polymers (MIPs) for detecting formaldehyde vapors in air streams. A copolymer thin film consisting of styrene, methacrylic acid, and ethylene glycol dimethacrylate on quartz crystal microbalance (QCM) yielded a detection limit of 500 ppb formaldehyde in dry air. Surprisingly, these MIPs showed specific behavior when tested against a range of volatile organic compounds (VOCs), such as acetaldehyde, methanol, formic acid, and dichloromethane. Despite thus being a suitable receptor in principle, the MIPs were not useful for measurements at 50% humidity due to surface saturation by water. This was overcome by introducing primary amino groups into the polymer via allyl amine and by changing the coating morphology from thin film to nanoparticles. This led to the same limit of detection (500 ppb) and selectivity as before, but at the real-life conditions of 50% relative humidity.
Open AccessMolecularly Imprinted Polymer Nanoparticles for Formaldehyde Sensing with QCM
Herein, we report on molecularly imprinted polymers (MIPs) for detecting formaldehyde vapors in air streams. A copolymer thin film consisting of styrene, methacrylic acid, and ethylene glycol dimethacrylate on quartz crystal microbalance (QCM) yielded a detection limit of 500 ppb formaldehyde in dry air. Surprisingly, these MIPs showed specific behavior when tested against a range of volatile organic compounds (VOCs), such as acetaldehyde, methanol, formic acid, and dichloromethane. Despite thus being a suitable receptor in principle, the MIPs were not useful for measurements at 50% humidity due to surface saturation by water. This was overcome by introducing primary amino groups into the polymer via allyl amine and by changing the coating morphology from thin film to nanoparticles. This led to the same limit of detection (500 ppb) and selectivity as before, but at the real-life conditions of 50% relative humidity.
- 25 September 2015
- Published by UK Journal of Pharmaceutical and Biosciences in Pharmaceutical and Biosciences Journal
- p. 18-29
A Straightforward Detection of HIT Type II via QCM-D
Heparin Induced Thrombocytopenia (HIT) is an undesired antibody based immune reaction against complexes of platelet factor 4 and heparin. HIT occurs in patients receiving heparin as anticoagulant over several days and is connected to the risk of life threatening thrombosis through intravasal platelet aggregation. HIT antibodies are routinely detected by Enzyme Linked Immunosorbent Assay (ELISA). However, not all antibodies lead to platelet aggregation and therefore, to clinical problems. The clinical relevance of a HIT ELISA positive serum can be confirmed by functional tests for platelet activation, like the heparin induced platelet activation (HIPA) test. However, these tests are tedious and cumbersome. Therefore, we present a straightforward approach by applying quartz crystal microbalance technology for functional assays for diagnosis of HIT type II. We utilized the qCell T (quartz crystal microbalance with dissipation (QCM-D)) platform of 3T analytik, Tuttlingen, Germany to demonstrate platelet aggregation measurements induced by clinically relevant HIT positive type II sera of patients. During the measurements changes in frequency and dissipation were recorded. This revealed statistically significant differences between high and low dose measurements in both, PRP and washed platelets. Platelet adhesion to the sensor surfaces was visualized by scanning electron microscopy (SEM). QCM-D data was in good accordance to SEM images. The results presented here promising that in the future specially adapted QCM-D sensors could be a serious straight forward alternative to currently used functional HIT assays.
- 25 September 2015
- Published by UK Journal of Pharmaceutical and Biosciences in Pharmaceutical and Biosciences Journal
- p. 18-29
A Straightforward Detection of HIT Type II via QCM-D
Heparin Induced Thrombocytopenia (HIT) is an undesired antibody based immune reaction against complexes of platelet factor 4 and heparin. HIT occurs in patients receiving heparin as anticoagulant over several days and is connected to the risk of life threatening thrombosis through intravasal platelet aggregation. HIT antibodies are routinely detected by Enzyme Linked Immunosorbent Assay (ELISA). However, not all antibodies lead to platelet aggregation and therefore, to clinical problems. The clinical relevance of a HIT ELISA positive serum can be confirmed by functional tests for platelet activation, like the heparin induced platelet activation (HIPA) test. However, these tests are tedious and cumbersome. Therefore, we present a straightforward approach by applying quartz crystal microbalance technology for functional assays for diagnosis of HIT type II. We utilized the qCell T (quartz crystal microbalance with dissipation (QCM-D)) platform of 3T analytik, Tuttlingen, Germany to demonstrate platelet aggregation measurements induced by clinically relevant HIT positive type II sera of patients. During the measurements changes in frequency and dissipation were recorded. This revealed statistically significant differences between high and low dose measurements in both, PRP and washed platelets. Platelet adhesion to the sensor surfaces was visualized by scanning electron microscopy (SEM). QCM-D data was in good accordance to SEM images. The results presented here promising that in the future specially adapted QCM-D sensors could be a serious straight forward alternative to currently used functional HIT assays.
- 17 June 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (68) , 54963-54970
Ultra-sensitive detection of heparin via aPTT using plastic antibodies on QCM-D platform
One of the challenges faced by today's clinics is unavailability of practical, precise and accurate determination of the most commonly used anti-coagulant ‘heparin’ in human blood/plasma in surgery. This is the first report of the application of a heparin imprinted thin film on a Quartz Crystal Microbalance with Dissipation (QCM-D) platform. Based on a novel, straight-forward and robust imprinting approach, a lowest volume consumption of 2 μL of real sample (of human plasma) has been demonstrated. This is a leap for launching spot testing for heparin sensing in laboratory practice. This approach could shorten the coagulation times to 48% and 45% for clinically important sensing range of heparin doses of 0.75 and 0.50 IU mL−1 respectively and could improve precision 3-fold (n = 20 samples) compared to that of today's 'gold standard'. Activated partial thromboplastin time (aPTT) on the plastic antibodies based QCM-D platform for plasma with doses of heparin 0.75 IU mL−1 and 0.50 IU mL−1 yielded 6.5% and 5% lower %RSD respectively as compared to that of the ‘gold standard’. The present studies could provide a launch pad to laboratory methods for ultra-refining of point of care (POC) settings in the perspectives of coagulation time shortening, precision of the method and sample volume consumption.
- 17 June 2015
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 5 (68) , 54963-54970
Ultra-sensitive detection of heparin via aPTT using plastic antibodies on QCM-D platform
One of the challenges faced by today's clinics is unavailability of practical, precise and accurate determination of the most commonly used anti-coagulant ‘heparin’ in human blood/plasma in surgery. This is the first report of the application of a heparin imprinted thin film on a Quartz Crystal Microbalance with Dissipation (QCM-D) platform. Based on a novel, straight-forward and robust imprinting approach, a lowest volume consumption of 2 μL of real sample (of human plasma) has been demonstrated. This is a leap for launching spot testing for heparin sensing in laboratory practice. This approach could shorten the coagulation times to 48% and 45% for clinically important sensing range of heparin doses of 0.75 and 0.50 IU mL−1 respectively and could improve precision 3-fold (n = 20 samples) compared to that of today's 'gold standard'. Activated partial thromboplastin time (aPTT) on the plastic antibodies based QCM-D platform for plasma with doses of heparin 0.75 IU mL−1 and 0.50 IU mL−1 yielded 6.5% and 5% lower %RSD respectively as compared to that of the ‘gold standard’. The present studies could provide a launch pad to laboratory methods for ultra-refining of point of care (POC) settings in the perspectives of coagulation time shortening, precision of the method and sample volume consumption.
- 1 April 2015
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 66, 579-584
QCM-D providing new horizon in the domain of sensitivity range and information for haemostasis of human plasma
- 1 April 2015
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 66, 579-584
QCM-D providing new horizon in the domain of sensitivity range and information for haemostasis of human plasma
- Open Access
- 6 February 2013
- Published by MDPI AG in Biosensors
- Vol. 3 (1) , 89-107
Biomimetic Strategies for Sensing Biological Species
The starting point of modern biosensing was the application of actual biological species for recognition. Increasing understanding of the principles underlying such recognition (and biofunctionality in general), however, has triggered a dynamic field in chemistry and materials sciences that aims at joining the best of two worlds by combining concepts derived from nature with the processability of manmade materials, e.g., sensitivity and ruggedness. This review covers different biomimetic strategies leading to highly selective (bio)chemical sensors: the first section covers molecularly imprinted polymers (MIP) that attempt to generate a fully artificial, macromolecular mold of a species in order to detect it selectively. A different strategy comprises of devising polymer coatings to change the biocompatibility of surfaces that can also be used to immobilized natural receptors/ligands and thus stabilize them. Rationally speaking, this leads to self-assembled monolayers closely resembling cell membranes, sometimes also including bioreceptors. Finally, this review will highlight some approaches to generate artificial analogs of natural recognition materials and biomimetic approaches in nanotechnology. It mainly focuses on the literature published since 2005.
- 6 February 2013
- Published by MDPI AG in Biosensors
- Vol. 3 (1) , 89-107
Open AccessBiomimetic Strategies for Sensing Biological Species
The starting point of modern biosensing was the application of actual biological species for recognition. Increasing understanding of the principles underlying such recognition (and biofunctionality in general), however, has triggered a dynamic field in chemistry and materials sciences that aims at joining the best of two worlds by combining concepts derived from nature with the processability of manmade materials, e.g., sensitivity and ruggedness. This review covers different biomimetic strategies leading to highly selective (bio)chemical sensors: the first section covers molecularly imprinted polymers (MIP) that attempt to generate a fully artificial, macromolecular mold of a species in order to detect it selectively. A different strategy comprises of devising polymer coatings to change the biocompatibility of surfaces that can also be used to immobilized natural receptors/ligands and thus stabilize them. Rationally speaking, this leads to self-assembled monolayers closely resembling cell membranes, sometimes also including bioreceptors. Finally, this review will highlight some approaches to generate artificial analogs of natural recognition materials and biomimetic approaches in nanotechnology. It mainly focuses on the literature published since 2005.